Late filing
Filing comparison
20/20 Biolabs, Inc. told the SEC it could not file its quarterly report on time
Does not expect a significant change in results. Filed on the statutory due date.
The Registrant is unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 (the “Form 10-Q”) because of unanticipated delays in the completion of its financial statements and related portions of the Form 10-Q, which delays could not be eliminated by the Registrant without unreasonable effort and expense.
Evidence
- Anticipates significant change
- No
- Days past due date
- 0
- Other periodic reports filed
- Yes
- Routine
- Yes
- Severity
- normal
- Source
- Form 12b-25 (notification of late filing)
- Stated reason
- The Registrant is unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 (the “Form 10-Q”) because of unanticipated delays in the completion of its financial statements and related portions of the Form 10-Q, which delays could not be eliminated by the Registrant without unreasonable effort and expense.
- Why
- The company told the SEC it could not file a periodic report on time, using Form 12b-25.